| LXP |
LXP Industrial Trust |
Andrawis Nabil |
Officer
|
2026-01-05 |
F - D |
705 |
49.61 |
34,975.05 |
50,356 |
| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
Andreessen Marc L |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
Andreessen Marc L |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
Andreessen Marc L |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
Andreessen Marc L |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
Andreessen Marc L |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
Andreessen Marc L |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
CLF Partners, LP |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
CLF Partners, LP |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| NAVN |
Navan, Inc. |
Andreessen Marc L |
10% Owner
|
2026-01-05 |
P - A |
202,729 |
15.77 |
3,197,036.33 |
7,992,267 |
| PBBK |
PB Bankshares, Inc. |
Andress Spencer J |
Director
|
2026-01-05 |
D - D |
12,500 |
0.00 |
0.00 |
0 |
| PBBK |
PB Bankshares, Inc. |
Andress Spencer J |
Director
|
2026-01-05 |
D - D |
10,000 |
0.00 |
0.00 |
0 |
|
Anixa Biosciences Inc |
Baskies Arnold M |
Director
|
2026-01-05 |
A - A |
25,000 |
0.00 |
0.00 |
25,000 |
|
Anixa Biosciences Inc |
Catelani Michael |
Officer
|
2026-01-05 |
A - A |
175,000 |
0.00 |
0.00 |
175,000 |
|
Anixa Biosciences Inc |
Gottschalk Emily |
Director
|
2026-01-05 |
A - A |
25,000 |
0.00 |
0.00 |
25,000 |
|
Anixa Biosciences Inc |
KUMAR AMIT |
Director
Officer
|
2026-01-05 |
A - A |
350,000 |
0.00 |
0.00 |
350,000 |
|
Anixa Biosciences Inc |
Titterton Lewis H jr |
Director
|
2026-01-05 |
A - A |
25,000 |
0.00 |
0.00 |
25,000 |
| INDI |
indie Semiconductor, Inc. |
Aoki Ichiro |
|
2026-01-05 |
S - D |
665 |
3.67 |
2,438.69 |
101,248 |
| INDI |
indie Semiconductor, Inc. |
Aoki Ichiro |
|
2026-01-05 |
S - D |
3,913 |
3.67 |
14,349.75 |
97,335 |
| INDI |
indie Semiconductor, Inc. |
Aoki Ichiro |
|
2026-01-05 |
S - D |
2,610 |
3.67 |
9,571.39 |
94,725 |
| APLS |
Apellis Pharmaceuticals, Inc. |
Baumal Caroline |
Officer
|
2026-01-05 |
S - D |
3,020 |
25.53 |
77,096.67 |
91,206 |